Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 88Neoplasm Metastasis 76Colorectal Neoplasms 75Neoplasms 73Leukemia, Myeloid, Acute 64Breast Neoplasms 57Prostatic Neoplasms 48Multiple Myeloma 48Ovarian Neoplasms 44Pancreatic Neoplasms 42Squamous Cell Carcinoma of Head and Neck 39Melanoma 37Recurrence 36Glioblastoma 33Lung Neoplasms 32Triple Negative Breast Neoplasms 31Lymphoma, Non-Hodgkin 31Myelodysplastic Syndromes 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Endometrial Neoplasms 27Advanced Solid Tumors 27Stomach Neoplasms 25Carcinoma, Renal Cell 25Small Cell Lung Carcinoma 24Sarcoma 23Brain Neoplasms 23Carcinoma, Hepatocellular 21Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell 19Esophageal Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Infectious Mononucleosis × 30 days × Clear all
NCT06908096 2026-05-18

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
750 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡